379 related articles for article (PubMed ID: 25799995)
41. Requirement for antiapoptotic MCL-1 in the survival of BCR-ABL B-lineage acute lymphoblastic leukemia.
Koss B; Morrison J; Perciavalle RM; Singh H; Rehg JE; Williams RT; Opferman JT
Blood; 2013 Aug; 122(9):1587-98. PubMed ID: 23881917
[TBL] [Abstract][Full Text] [Related]
42. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation.
Kashiwada M; Giallourakis CC; Pan PY; Rothman PB
J Immunol; 2001 Dec; 167(11):6382-7. PubMed ID: 11714803
[TBL] [Abstract][Full Text] [Related]
43. BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.
Juszczynski P; Chen L; O'Donnell E; Polo JM; Ranuncolo SM; Dalla-Favera R; Melnick A; Shipp MA
Blood; 2009 Dec; 114(26):5315-21. PubMed ID: 19855081
[TBL] [Abstract][Full Text] [Related]
44. Mercury alters endogenous phosphorylation profiles of SYK in murine B cells.
Caruso JA; Carruthers N; Shin N; Gill R; Stemmer PM; Rosenspire A
BMC Immunol; 2017 Jul; 18(1):37. PubMed ID: 28716125
[TBL] [Abstract][Full Text] [Related]
45. Syk mediates BCR- and CD40-signaling integration during B cell activation.
Ying H; Li Z; Yang L; Zhang J
Immunobiology; 2011 May; 216(5):566-70. PubMed ID: 21074890
[TBL] [Abstract][Full Text] [Related]
46. Cross-linking of B cell antigen receptor-related structure of pre-B cell lines induces tyrosine phosphorylation of p85 and p110 subunits and activation of phosphatidylinositol 3-kinase.
Kuwahara K; Kawai T; Mitsuyoshi S; Matsuo Y; Kikuchi H; Imajoh-Ohmi S; Hashimoto E; Inui S; Cooper MD; Sakaguchi N
Int Immunol; 1996 Aug; 8(8):1273-85. PubMed ID: 8918697
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms of pre-B-cell receptor checkpoint control and its oncogenic subversion in acute lymphoblastic leukemia.
Buchner M; Swaminathan S; Chen Z; Müschen M
Immunol Rev; 2015 Jan; 263(1):192-209. PubMed ID: 25510278
[TBL] [Abstract][Full Text] [Related]
48. Spatial coupling of JNK activation to the B cell antigen receptor by tyrosine-phosphorylated ezrin.
Parameswaran N; Enyindah-Asonye G; Bagheri N; Shah NB; Gupta N
J Immunol; 2013 Mar; 190(5):2017-26. PubMed ID: 23338238
[TBL] [Abstract][Full Text] [Related]
49. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.
Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV
Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826
[TBL] [Abstract][Full Text] [Related]
50. Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells.
Hüttl S; Kläsener K; Schweizer M; Schneppenheim J; Oberg HH; Kabelitz D; Reth M; Saftig P; Schröder B
J Immunol; 2015 Aug; 195(4):1548-63. PubMed ID: 26157172
[TBL] [Abstract][Full Text] [Related]
51. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt.
Craxton A; Jiang A; Kurosaki T; Clark EA
J Biol Chem; 1999 Oct; 274(43):30644-50. PubMed ID: 10521450
[TBL] [Abstract][Full Text] [Related]
52. Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells.
Gioia R; Leroy C; Drullion C; Lagarde V; Etienne G; Dulucq S; Lippert E; Roche S; Mahon FX; Pasquet JM
Blood; 2011 Aug; 118(8):2211-21. PubMed ID: 21730355
[TBL] [Abstract][Full Text] [Related]
53. Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemia.
Müschen M
Blood; 2015 Jun; 125(24):3688-93. PubMed ID: 25878119
[TBL] [Abstract][Full Text] [Related]
54. Co-clustering of Fcgamma and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein.
Koncz G; Tóth GK; Bökönyi G; Kéri G; Pecht I; Medgyesi D; Gergely J; Sármay G
Eur J Biochem; 2001 Jul; 268(14):3898-906. PubMed ID: 11453982
[TBL] [Abstract][Full Text] [Related]
55. Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition.
Köhrer S; Havranek O; Seyfried F; Hurtz C; Coffey GP; Kim E; Ten Hacken E; Jäger U; Vanura K; O'Brien S; Thomas DA; Kantarjian H; Ghosh D; Wang Z; Zhang M; Ma W; Jumaa H; Debatin KM; Müschen M; Meyer LH; Davis RE; Burger JA
Leukemia; 2016 Jun; 30(6):1246-54. PubMed ID: 26847027
[TBL] [Abstract][Full Text] [Related]
56. Abelson tyrosine kinase controls BCR signalling and B-cell differentiation by promoting B-cell metabolism.
Luo L; Jiang P; Chen Q; Chang J; Jing Y; Luo X; Gu H; Huang Y; Chen R; Liu J; Kang D; Liu Q; Wang Y; Fang G; Zhu Y; Guan F; Lei J; Yang L; Liu C; Dai X
Immunology; 2022 Oct; 167(2):181-196. PubMed ID: 35753034
[TBL] [Abstract][Full Text] [Related]
57. Functional analysis of Csk in signal transduction through the B-cell antigen receptor.
Hata A; Sabe H; Kurosaki T; Takata M; Hanafusa H
Mol Cell Biol; 1994 Nov; 14(11):7306-13. PubMed ID: 7935444
[TBL] [Abstract][Full Text] [Related]
58. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
Nakamura K; Cambier JC
J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
[TBL] [Abstract][Full Text] [Related]
59. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
[TBL] [Abstract][Full Text] [Related]
60. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
